Stammdaten
Oaktree Acquisition Corp. III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.
Unternehmen & Branche
| Name | Oaktree Acquisition Corp. III Life Sciences |
|---|---|
| Ticker | OACC |
| CIK | 0002029769 |
| Boerse | US |
| Sektor | Financial Services |
| Industrie | Shell Companies |
| SIC | 6770 · Blank Checks |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 261,8 Mio. USD |
| Beta | -0,04 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 7,288,824 | 203,111,772 | -6,770,157 | ||
| 2025-09-30 | 10-Q | 1,966,742 | 201,249,963 | -6,764,662 | ||
| 2025-06-30 | 10-Q | 1,874,343 | 199,175,668 | -6,539,083 | ||
| 2025-03-31 | 10-Q | 1,658,791 | 197,240,594 | -6,519,273 | ||
| 2024-12-31 | 10-K | 1,331,707 | 195,250,622 | -6,074,471 | ||
| 2024-09-30 | 10-Q | -48,095 | -23,095 | |||
| 2024-06-30 | 10-Q | 0 | 25,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.